Association of chondroadherin with leiomyosarcoma
The leiomyosarcoma (LMS) subtype of uterine sarcoma accounts for 1–2 % of uterine neoplasia cases. The present study aimed to demonstrate that the gene and protein chondroadherin (CHAD) levels may serve as novel biomarkers for predicting prognosis and devising novel treatment models for LMS. A total...
| Glavni autori: | , , , , |
|---|---|
| Format: | Članak |
| Jezik: | English |
| Izdano: |
Elsevier
2023-04-01
|
| Serija: | Gynecologic Oncology Reports |
| Teme: | |
| Online pristup: | http://www.sciencedirect.com/science/article/pii/S2352578923000139 |